BackLux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview

Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) Other Current Liabilities

Track Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s other current liabilities ($860K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$860511.00
310.94% YoYΔ $651111.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) Other Current Liabilities History

Loading

Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) vs. peers: Other Current Liabilities Comparison

Loading

Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War) (LUXAU) FAQ

The latest other current liabilities for LUXAU is $860K as of June 2022. That compares with $210K in the prior-year period — up 310.9% year over year. Investors often review this figure alongside Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LUXAU's other current liabilities moved from $210K to $860K — a 310.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lux Health Tech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s operating scale or balance-sheet position.

A other current liabilities figure of $860K for LUXAU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LUXAU's other current liabilities ($860K), review year-over-year change from $210K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.